Millar, Inc. Announces the Sale of Life Sciences Telemetry Product Line to Kaha Sciences

Millar, Inc. Announces the Sale of Life Sciences Telemetry Product Line to Kaha Sciences

HOUSTON, Dec. 13, 2017 /PRNewswire/ -- Millar, Inc. a leader in medical device manufacturing, today announces the sale of the life sciences telemetry product division to Kaha Sciences, located in Auckland, New Zealand. The transition of this product line from Millar will be complete by Dec. 31, 2017. 

This change in Millar's product portfolio continues the company strategy to focus all efforts on growing the clinical and OEM business segments. The company began moving in this direction earlier this year with the launch of the OEM division and website.

Kaha Sciences has employed several key Millar telemetry staff that previously supported the product line, ensuring customers with the same level of dedicated service, support and knowledge. In addition, the return and appointment of Joe Simonetta as CEO of Kaha Sciences provides a consistent transition due to his understanding of the telemetry product, market and customers.

Tim Daugherty, CEO at Millar, stated, "Millar is fully committed to developing novel clinical devices for the Heart Failure and Structural Heart markets, while improving its MEMS pressure sensor and wireless technology platforms for integration into partner companies' devices with the potential to impact a thousand times more patients than Millar can reach on its own. The transition of the telemetry product to Kaha Sciences ensures that our customers are fully supported going forward and enables continued innovation in the basic sciences market."  

This transition further supports Millar's core business purpose and provides greater momentum towards improving medical understanding and the health of mankind by bringing new technology to the market faster.

About Millar, Inc.
Since 1969, Millar, Inc. has led the development of catheter-based, solid-state pressure sensors and is known worldwide as the leader in sensors that advance medical understanding. Millar delivers precision catheter-based technology to measure high-fidelity physiological parameters for improved accuracy in patient evaluation. Today the company's clinical and life sciences products empower medical discovery and allow advanced cardiovascular diagnosis. Millar also delivers OEM solutions to the medical device and life sciences industries through our MEMS pressure sensors, ISO 13485 precision manufacturing and wireless power technology.

About Kaha Sciences
The company Kaha Sciences Ltd is newly established (2017); however, many of its staff have been working with the Millar telemetry products for over a decade.  In New Zealand's indigenous language, Te Reo Maori, Kaha means to be strong, able, capable, courageous, intense, energetic, all qualities that we believe symbolize our confidence in our telemetry system and the contribution it makes to our customers' scientific studies. Kaha Sciences sees this as a seamless transition and will continue to provide the best telemetry solutions and second-to-none support to existing and new customers.